The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity
Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic cha...
Saved in:
Published in | International Journal of Obesity Vol. 39; no. 8; pp. 1241 - 1248 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.08.2015
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0307-0565 1476-5497 1476-5497 |
DOI | 10.1038/ijo.2015.65 |
Cover
Loading…
Abstract | Objectives:
Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.
Methods:
We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.
Results:
A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.
Conclusion:
Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. |
---|---|
AbstractList | Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.
We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.
A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.
Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65 Objectives:Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.Methods:We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.Results:A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.Conclusion:Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. OBJECTIVES: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. METHODS: We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. RESULTS: A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. CONCLUSION: Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65 Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. Methods: We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. Results: A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. Conclusion: Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.OBJECTIVESMechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.METHODSWe recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.RESULTSA differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.CONCLUSIONDifferent metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. |
Audience | Academic |
Author | Chang, C-S Yao, W-J Tsai, Y-S Kuo, P-H Kuo, T-C Chen, H-H Wang, S-Y Tseng, Y J Wu, C-H Shieh, C-C |
Author_xml | – sequence: 1 givenname: H-H surname: Chen fullname: Chen, H-H organization: Department of Public Health and Institute of Epidemiology and Preventive Medicine, National Taiwan University – sequence: 2 givenname: Y J surname: Tseng fullname: Tseng, Y J organization: School of Pharmacy, College of Medicine, National Taiwan University, Department of Computer Science and Information Engineering, National Taiwan University, Graduate Institute of Biomedical Electronic and Bioinformatics, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University – sequence: 3 givenname: S-Y surname: Wang fullname: Wang, S-Y organization: Department of Computer Science and Information Engineering, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University – sequence: 4 givenname: Y-S surname: Tsai fullname: Tsai, Y-S organization: Institute of Clinical Medicine, National Cheng Kung University Medical College – sequence: 5 givenname: C-S surname: Chang fullname: Chang, C-S organization: Institute of Clinical Medicine, National Cheng Kung University Medical College, Department of Family Medicine, National Cheng Kung University Hospital – sequence: 6 givenname: T-C surname: Kuo fullname: Kuo, T-C organization: Graduate Institute of Biomedical Electronic and Bioinformatics, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University – sequence: 7 givenname: W-J surname: Yao fullname: Yao, W-J organization: Department of Nuclear Medicine, National Cheng Kung University Hospital – sequence: 8 givenname: C-C surname: Shieh fullname: Shieh, C-C organization: Institute of Clinical Medicine, National Cheng Kung University Medical College – sequence: 9 givenname: C-H surname: Wu fullname: Wu, C-H email: paulo@mail.ncku.edu.tw organization: Department of Family Medicine, National Cheng Kung University Hospital, Institute of Behavioral Medicine, National Cheng Kung University Medical College – sequence: 10 givenname: P-H surname: Kuo fullname: Kuo, P-H email: phkuo@ntu.edu.tw organization: Department of Public Health and Institute of Epidemiology and Preventive Medicine, National Taiwan University, Research Center for Genes, Environment and Human Health, National Taiwan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25907313$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0s1r1EAUAPBBKnZbPXmXgCAFzTofma9jKdUWCr1UPA6T5GV3lsnMmkmQ_PfOuq22pUrJITn83kfee0foIMQACL0leEkwU5_dJi4pJnwp-Au0IJUUJa-0PEALzLAsMRf8EB2ltMEYc47pK3RIucaSEbZA32_WUPQw2jr62EOxHWLnvAurwoa22Npx_dPO-dv6OblUuHCHXVOswfpxPf-Wtg5x6K0vYg3JjfNr9LKzPsGb2_cx-vbl_Obsory6_np5dnpVNlzqsQTQVFJdYQaiEyr3BDL_SsMBWsw6q1XHmBC1JtTWjVKVBdG20OlKYWx1xY7RyT5vbvzHBGk0vUsNeG8DxCkZIhlVVOQCz6CYYqWJkJm-f0Q3cRryEJKhjBFBuaTifyrnIlRVlFd_1cp6MC50cRxssyttTjNQhOQRZLV8QuWnhd41eeF5K_Aw4MO9gP0qUvTT6GJID-G72y6nuofWbAfX22E2dzeQwcc9aIaY0gDdH0Kw2V2YyRdmdhdmBM-aPNKNG-2uam7Y-X_EfNrHpJw5rGC4N6gn-C_Q4t2l |
CitedBy_id | crossref_primary_10_1039_C6FO00993J crossref_primary_10_3389_fendo_2023_1151757 crossref_primary_10_1016_j_diabres_2021_109077 crossref_primary_10_1155_2016_2108909 crossref_primary_10_3389_fnins_2025_1498981 crossref_primary_10_1093_hmg_ddv375 crossref_primary_10_3390_molecules25112477 crossref_primary_10_3945_jn_115_219147 crossref_primary_10_3390_antiox13030302 crossref_primary_10_1002_oby_21724 crossref_primary_10_1039_D0FO01275K crossref_primary_10_1371_journal_pone_0143190 crossref_primary_10_1534_genetics_117_300280 crossref_primary_10_3390_foods11193000 crossref_primary_10_1038_s41416_022_01873_9 crossref_primary_10_1038_s41598_023_39661_x crossref_primary_10_1186_s12882_020_02164_2 crossref_primary_10_3390_metabo11070448 crossref_primary_10_1007_s12282_024_01579_1 crossref_primary_10_1016_j_isci_2020_100977 crossref_primary_10_3346_jkms_2020_35_e273 crossref_primary_10_1002_advs_202309525 crossref_primary_10_1177_1469066720964632 crossref_primary_10_13005_bpj_2274 crossref_primary_10_5812_jjnpp_107566 crossref_primary_10_1016_j_sjbs_2020_03_015 crossref_primary_10_1016_j_aquaculture_2018_03_050 crossref_primary_10_1021_acs_jproteome_1c00879 crossref_primary_10_18705_1607_419X_2021_27_3_279_290 crossref_primary_10_1007_s00204_023_03474_8 crossref_primary_10_1038_s41564_018_0146_2 crossref_primary_10_1039_C8FO02334D crossref_primary_10_1371_journal_pone_0231506 crossref_primary_10_1089_cmb_2018_0185 crossref_primary_10_1093_advances_nmac103 crossref_primary_10_1134_S1061934819040051 crossref_primary_10_1186_s12986_016_0095_9 crossref_primary_10_2147_DMSO_S337979 crossref_primary_10_1186_s12944_020_01273_z crossref_primary_10_3389_fendo_2021_761547 crossref_primary_10_1002_2211_5463_13788 crossref_primary_10_1007_s11886_020_01422_x crossref_primary_10_3390_metabo12020161 crossref_primary_10_1021_acs_jproteome_7b00855 crossref_primary_10_1007_s40201_024_00912_2 crossref_primary_10_1039_C6FO01753C crossref_primary_10_3390_ijms21134652 crossref_primary_10_3390_antiox11040774 crossref_primary_10_1016_j_rehab_2016_07_262 crossref_primary_10_1186_s12859_016_1292_2 crossref_primary_10_1038_s41598_018_33540_6 crossref_primary_10_1172_jci_insight_158037 crossref_primary_10_1002_oby_21482 crossref_primary_10_3389_fphys_2021_731762 crossref_primary_10_1002_oby_22694 crossref_primary_10_1161_JAHA_121_021369 crossref_primary_10_3390_metabo11060392 crossref_primary_10_1002_oby_22336 crossref_primary_10_3390_nu8060324 crossref_primary_10_3390_biomedicines10112891 crossref_primary_10_1186_s12859_016_1335_8 crossref_primary_10_1016_j_diabres_2015_12_024 crossref_primary_10_1007_s40200_021_00917_w crossref_primary_10_1210_clinem_dgac160 crossref_primary_10_1038_srep30958 crossref_primary_10_1080_02652048_2022_2061058 crossref_primary_10_1007_s10695_019_00669_8 crossref_primary_10_1155_2022_2739772 crossref_primary_10_3389_fmolb_2023_1166333 crossref_primary_10_1017_S0007114522003385 crossref_primary_10_3390_toxics12040288 crossref_primary_10_3390_nu16203501 crossref_primary_10_1016_j_cmet_2018_09_022 crossref_primary_10_1016_j_tem_2017_07_001 crossref_primary_10_3168_jds_2019_17114 crossref_primary_10_1016_j_lfs_2023_122180 crossref_primary_10_1021_acs_jafc_8b00421 crossref_primary_10_1016_j_clnu_2019_04_025 crossref_primary_10_3390_metabo12080677 crossref_primary_10_1016_j_psj_2020_05_025 crossref_primary_10_1007_s11306_016_1114_6 crossref_primary_10_1097_FJC_0000000000000776 crossref_primary_10_1039_C6RA28715H crossref_primary_10_1016_j_aqrep_2019_100271 crossref_primary_10_1038_ijo_2017_288 crossref_primary_10_2147_DMSO_S294894 crossref_primary_10_1016_j_phymed_2024_156355 crossref_primary_10_1111_nmo_13178 crossref_primary_10_3389_fcdhc_2022_980856 crossref_primary_10_2147_DDDT_S379335 crossref_primary_10_1097_NNR_0000000000000783 crossref_primary_10_4239_wjd_v12_i4_420 crossref_primary_10_1007_s00508_022_02146_4 crossref_primary_10_2147_DMSO_S301363 crossref_primary_10_3389_fendo_2021_637317 crossref_primary_10_1021_acs_jproteome_7b00802 crossref_primary_10_1111_dom_15395 crossref_primary_10_1038_s41598_017_02856_0 crossref_primary_10_3390_metabo13050641 |
Cites_doi | 10.1161/CIRCULATIONAHA.111.027375 10.1038/nm.2307 10.1021/bi00249a015 10.1016/j.atherosclerosis.2008.05.022 10.1007/s00125-009-1637-8 10.1007/S11745-000-0593-z 10.2337/DC11-1577 10.1039/b914182k 10.1042/BJ20060221 10.2337/dc12-1971 10.1001/archinte.165.7.742 10.1097/AOG.0b013e318255004e 10.1001/jama.282.16.1519 10.1210/jc.2007-2724 10.1038/ijo.2010.44 10.1001/archinte.168.15.1617 10.5936/csbj.201301009 10.1016/j.jchromb.2011.08.014 10.1152/ajpregu.00103.2004 10.1152/ajpcell.1997.272.1.C289 10.1371/journal.pone.0010883 10.1016/j.abb.2008.10.011 10.1038/nature07540 10.1172/JCI63967 10.1210/jc.2014-3157 10.1111/j.1523-1755.2004.00963.x 10.1016/j.bbabio.2012.11.014 10.1007/s11695-008-9521-z 10.1093/nar/gkr988 10.1210/jc.2011-3475 10.2337/db06-0062 10.1016/S1590-8658(00)80825-7 10.1038/oby.2009.510 10.1023/A:1027332523114 10.1093/ajcn/86.6.1687 10.1016/j.nutres.2010.09.007 10.1210/jc.2005-0482 10.1016/j.braindev.2010.06.016 10.1159/000343204 10.1016/j.cmet.2009.02.002 10.1021/bi9722507 10.1089/109662002753723197 10.1042/bj3200345 10.1053/j.gastro.2008.09.018 10.1021/pr100101p 10.2337/dc09-0574 10.2337/diacare.27.5.1182 10.1038/msb.2008.50 10.1038/nrendo.2014.171 10.1111/j.1463-1326.2008.00866.x 10.1016/j.amjhyper.2006.06.015 10.1053/j.ajkd.2006.09.004 10.1002/jms.3154 10.1007/s11306-012-0434-4 10.1152/physiolgenomics.00194.2006 10.2337/diabetes.54.1.8 10.2337/db13-0719 10.1093/bioinformatics/btq418 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2015 COPYRIGHT 2015 Nature Publishing Group Copyright Nature Publishing Group Aug 2015 Macmillan Publishers Limited 2015. |
Copyright_xml | – notice: Macmillan Publishers Limited 2015 – notice: COPYRIGHT 2015 Nature Publishing Group – notice: Copyright Nature Publishing Group Aug 2015 – notice: Macmillan Publishers Limited 2015. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U 7X8 |
DOI | 10.1038/ijo.2015.65 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Agricultural & Environmental Science & Pollution Managment ProQuest Central Essentials Biological Science Collection Proquest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database Physical Education Index MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
EISSN | 1476-5497 |
EndPage | 1248 |
ExternalDocumentID | 3767656231 A425811927 25907313 10_1038_ijo_2015_65 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABIVO ABJNI ABLJU ABRTQ ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADHUB ADXHL AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV AMYLF APEBS ATHPR AXYYD AYFIA BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PKEHL PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c579t-ee92729403e6f68731e7015c5eed03fa98f3366b912abc884ae6ddef94800a943 |
IEDL.DBID | 7X7 |
ISSN | 0307-0565 1476-5497 |
IngestDate | Fri Jul 11 07:07:43 EDT 2025 Fri Jul 11 00:52:40 EDT 2025 Thu Jul 17 02:13:47 EDT 2025 Wed Jul 16 16:06:30 EDT 2025 Tue Jun 17 21:40:17 EDT 2025 Tue Jun 10 20:12:18 EDT 2025 Thu May 22 21:17:52 EDT 2025 Mon Jul 21 06:01:38 EDT 2025 Tue Jul 01 03:01:54 EDT 2025 Thu Apr 24 22:58:28 EDT 2025 Fri Feb 21 02:39:11 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c579t-ee92729403e6f68731e7015c5eed03fa98f3366b912abc884ae6ddef94800a943 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25907313 |
PQID | 1701284254 |
PQPubID | 38864 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1732826403 proquest_miscellaneous_1702089167 proquest_journals_2331625726 proquest_journals_1701284254 gale_infotracmisc_A425811927 gale_infotracacademiconefile_A425811927 gale_healthsolutions_A425811927 pubmed_primary_25907313 crossref_primary_10_1038_ijo_2015_65 crossref_citationtrail_10_1038_ijo_2015_65 springer_journals_10_1038_ijo_2015_65 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-08-01 |
PublicationDateYYYYMMDD | 2015-08-01 |
PublicationDate_xml | – month: 08 year: 2015 text: 2015-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | Official journal of the International Association for the Study of Obesity |
PublicationTitle | International Journal of Obesity |
PublicationTitleAbbrev | Int J Obes |
PublicationTitleAlternate | Int J Obes (Lond) |
PublicationYear | 2015 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Mokdad, Serdula, Dietz, Bowman, Marks, Koplan (CR1) 1999; 282 Lee, Chang, Chiang, Liu, Yeh, Chen (CR47) 2011; 124 Brochu, Tchernof, Dionne, Sites, Eltabbakh, Sims (CR7) 2001; 86 Connor, Hansen, Corner, Smith, Ryan (CR9) 2010; 6 Kirchberg, Harder, Weber, Grote, Demmelmair, Peissner (CR28) 2015; 100 Turnbaugh, Hamady, Yatsunenko, Cantarel, Duncan, Ley (CR60) 2009; 457 Nilsen, Bjorke-Monsen, Midttun, Nygard, Pedersen, Ulvik (CR48) 2012; 119 Bartel, Krumsiek, Theis (CR18) 2013; 4 Wahl, Yu, Kleber, Singmann, Holzapfel, He (CR25) 2012; 5 Tai, Tan, Stevens, Low, Muehlbauer, Goh (CR26) 2010; 53 Shaham, Wei, Wang, Ricciardi, Lewis, Vasan (CR27) 2008; 4 Kuk, Ardern (CR16) 2009; 32 Dweikat, Naser, Abu Libdeh, Naser, Abu Gharbieh, Maraqa (CR33) 2011; 33 Konrad, Major, Wolf (CR50) 1994; 33 Wang, Feng, Sun, Li, Bi, Sun (CR14) 2011; 879 Schwab, Sauer, Okun, Nijtmans, Rodenburg, van den Heuvel (CR32) 2006; 398 Appleton, Seaborn, Visvanathan, Hill, Gill, Taylor (CR5) 2013; 36 Lara Baruque, Razquin, Jimenez, Vazquez, Gisbert, Pajares (CR45) 2000; 32 Levin (CR55) 2002; 5 Walsh, Brennan, Pujos-Guillot, Sebedio, Scalbert, Fagan (CR61) 2007; 86 Mihalik, Goodpaster, Kelley, Chace, Vockley, Toledo (CR12) 2009; 18 Coutinho Tde, Turner, Peyser, Bielak, Sheedy, Kullo (CR54) 2007; 20 Aguilar-Salinas, Garcia, Robles, Riano, Ruiz-Gomez, Garcia-Ulloa (CR2) 2008; 93 Lynch, Adams (CR30) 2014; 10 Wildman, Muntner, Reynolds, McGinn, Rajpathak, Wylie-Rosett (CR3) 2008; 168 Foster (CR34) 2012; 122 Ritov, Menshikova, He, Ferrell, Goodpaster, Kelley (CR31) 2005; 54 Bandyopadhyay, Yu, Ofrecio, Olefsky (CR35) 2006; 55 Karelis, Faraj, Bastard, St-Pierre, Brochu, Prud'homme (CR6) 2005; 90 Mracek, Pecinova, Vrbacky, Drahota, Houstek (CR39) 2009; 481 Eaton, Bartlett, Pourfarzam (CR22) 1996; 320 Alfadda, DosSantos, Stepanyan, Marrif, Silva (CR38) 2004; 287 Salek, Maguire, Bentley, Rubtsov, Hough, Cheeseman (CR59) 2007; 29 Swierczynski, Zabrocka, Goyke, Raczynska, Adamonis, Sledzinski (CR37) 2003; 254 Hamer, Stamatakis (CR4) 2012; 97 Kim, Park, Kim, Ham, Kim, Kwon (CR11) 2010; 9 Choi, Atkinson, Karlson, Curhan (CR53) 2005; 165 Kanehisa, Goto, Sato, Furumichi, Tanabe (CR20) 2011; 40 Calvani, Miccheli, Capuani, Tomassini Miccheli, Puccetti, Delfini (CR58) 2010; 34 Gu, A, Wang, Zha, Yan, Zhang (CR10) 2010; 24 Gall, Beebe, Lawton, Adam, Mitchell, Nakhle (CR23) 2010; 5 Wang, Larson, Vasan, Cheng, Rhee, McCabe (CR29) 2011; 17 Ramanadham, Hsu, Bohrer, Nowatzke, Ma, Turk (CR49) 1998; 37 Hsu, Bohrer, Wohltmann, Ramanadham, Ma, Yarasheski (CR51) 2000; 35 Dunn, Erban, Weber, Creek, Brown, Breitling (CR19) 2012; 9 Youn, Siu, Lob, Itani, Harrison, Cai (CR40) 2014; 63 Lu, Levin, Tagatose Donner (CR57) 2008; 10 Xia, Wishart (CR21) 2010; 26 Gagliardi, Miname, Santos (CR52) 2009; 202 Preet, Karve, Rizk, Cheema (CR8) 2012; S6 Cao, Honeyman, Cooney, Kennington, Scheid, Jonassen (CR42) 2004; 66 Newgard, An, Bain, Muehlbauer, Stevens, Lien (CR24) 2009; 9 Poore, Hurst, Assimos, Holmes (CR41) 1997; 272 Mracek, Drahota, Houstek (CR36) 2013; 1827 Ho, Kuo, Wang, Chen, Tseng (CR17) 2013; 48 Swierczynski, Sledzinski, Slominska, Smolenski, Sledzinski (CR44) 2008; 19 Mihalik, Michaliszyn, de Las Heras, Bacha, Lee, Chace (CR13) 2012; 35 Goessling, Massaro, Vasan, D'Agostino, Ellison, Fox (CR46) 2008; 135 Donner, Magder, Zarbalian (CR56) 2010; 30 Tan, Ma, Wai, Chew, Tai (CR15) 2004; 27 Taylor, Curhan (CR43) 2006; 48 M Kanehisa (BFijo201565_CR20) 2011; 40 O Shaham (BFijo201565_CR27) 2008; 4 R Calvani (BFijo201565_CR58) 2010; 34 JL Kuk (BFijo201565_CR16) 2009; 32 RP Wildman (BFijo201565_CR3) 2008; 168 A Preet (BFijo201565_CR8) 2012; S6 S Gu (BFijo201565_CR10) 2010; 24 Y Lu (BFijo201565_CR57) 2008; 10 M Hamer (BFijo201565_CR4) 2012; 97 S Wahl (BFijo201565_CR25) 2012; 5 AH Mokdad (BFijo201565_CR1) 1999; 282 J Swierczynski (BFijo201565_CR44) 2008; 19 DW Foster (BFijo201565_CR34) 2012; 122 RJ Konrad (BFijo201565_CR50) 1994; 33 M Brochu (BFijo201565_CR7) 2001; 86 SC Connor (BFijo201565_CR9) 2010; 6 VB Ritov (BFijo201565_CR31) 2005; 54 JY Kim (BFijo201565_CR11) 2010; 9 J Bartel (BFijo201565_CR18) 2013; 4 A Alfadda (BFijo201565_CR38) 2004; 287 FF Kirchberg (BFijo201565_CR28) 2015; 100 RM Nilsen (BFijo201565_CR48) 2012; 119 S Ramanadham (BFijo201565_CR49) 1998; 37 L-C Cao (BFijo201565_CR42) 2004; 66 EN Taylor (BFijo201565_CR43) 2006; 48 SJ Mihalik (BFijo201565_CR13) 2012; 35 FF Hsu (BFijo201565_CR51) 2000; 35 SL Appleton (BFijo201565_CR5) 2013; 36 C Wang (BFijo201565_CR14) 2011; 879 A Coutinho Tde (BFijo201565_CR54) 2007; 20 MC Walsh (BFijo201565_CR61) 2007; 86 S Eaton (BFijo201565_CR22) 1996; 320 IM Dweikat (BFijo201565_CR33) 2011; 33 PJ Turnbaugh (BFijo201565_CR60) 2009; 457 RM Salek (BFijo201565_CR59) 2007; 29 J Xia (BFijo201565_CR21) 2010; 26 S Lara Baruque (BFijo201565_CR45) 2000; 32 ACM Gagliardi (BFijo201565_CR52) 2009; 202 ES Tai (BFijo201565_CR26) 2010; 53 HK Choi (BFijo201565_CR53) 2005; 165 T Mracek (BFijo201565_CR39) 2009; 481 C-E Tan (BFijo201565_CR15) 2004; 27 AD Karelis (BFijo201565_CR6) 2005; 90 WB Dunn (BFijo201565_CR19) 2012; 9 MA Schwab (BFijo201565_CR32) 2006; 398 T Mracek (BFijo201565_CR36) 2013; 1827 W Goessling (BFijo201565_CR46) 2008; 135 WE Gall (BFijo201565_CR23) 2010; 5 RE Poore (BFijo201565_CR41) 1997; 272 TW Donner (BFijo201565_CR56) 2010; 30 GV Levin (BFijo201565_CR55) 2002; 5 GK Bandyopadhyay (BFijo201565_CR35) 2006; 55 J Swierczynski (BFijo201565_CR37) 2003; 254 YC Lee (BFijo201565_CR47) 2011; 124 JY Youn (BFijo201565_CR40) 2014; 63 CA Aguilar-Salinas (BFijo201565_CR2) 2008; 93 TJ Wang (BFijo201565_CR29) 2011; 17 SJ Mihalik (BFijo201565_CR12) 2009; 18 CJ Lynch (BFijo201565_CR30) 2014; 10 CB Newgard (BFijo201565_CR24) 2009; 9 TJ Ho (BFijo201565_CR17) 2013; 48 11238480 - J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5 16686602 - Biochem J. 2006 Aug 15;398(1):107-12 17941870 - Diabetes Obes Metab. 2008 Feb;10 (2):109-34 21147362 - Nutr Res. 2010 Dec;30(12 ):801-6 15855252 - J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50 20111019 - Obesity (Silver Spring). 2010 Sep;18(9):1695-700 20526369 - PLoS One. 2010 May 28;5(5):e10883 7947736 - Biochemistry. 1994 Nov 15;33(45):13284-94 17190852 - Physiol Genomics. 2007 Apr 24;29(2):99-108 20567778 - Mol Biosyst. 2010 May;6(5):909-21 12511110 - J Med Food. 2002 Spring;5(1):23-36 24688690 - Comput Struct Biotechnol J. 2013 Mar 22;4:e201301009 22508708 - J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8 18952046 - Arch Biochem Biophys. 2009 Jan 1;481(1):30-6 24550188 - Diabetes. 2014 Jul;63(7):2344-55 21844078 - Circulation. 2011 Sep 6;124(10 ):1160-71 9521776 - Biochemistry. 1998 Mar 31;37(13):4553-67 19043404 - Nature. 2009 Jan 22;457(7228):480-4 23491523 - Diabetes Care. 2013 Aug;36(8):2388-94 22080510 - Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14 15031134 - Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R147-56 15824292 - Arch Intern Med. 2005 Apr 11;165(7):742-8 20212498 - Int J Obes (Lond). 2010 Jun;34(6):1095-8 19729521 - Diabetes Care. 2009 Dec;32(12):2297-9 25287287 - Nat Rev Endocrinol. 2014 Dec;10(12):723-36 19010326 - Gastroenterology. 2008 Dec;135(6):1935-44, 1944.e1 20628077 - Bioinformatics. 2010 Sep 15;26(18):2342-4 18431611 - Obes Surg. 2009 Jul;19(7):883-9 23220394 - Biochim Biophys Acta. 2013 Mar;1827(3):401-10 18682704 - Mol Syst Biol. 2008;4:214 17162145 - Am J Kidney Dis. 2006 Dec;48(6):905-15 21423183 - Nat Med. 2011 Apr;17(4):448-53 15616005 - Diabetes. 2005 Jan;54(1):8-14 20076942 - Diabetologia. 2010 Apr;53(4):757-67 8973539 - Biochem J. 1996 Dec 1;320 ( Pt 2):345-57 18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24 14674682 - Mol Cell Biochem. 2003 Dec;254(1-2):55-9 25368978 - J Clin Endocrinol Metab. 2015 Jan;100(1):149-58 22833869 - J Clin Invest. 2012 Jun;122(6):1958-9 23108202 - Obes Facts. 2012;5(5):660-70 18065587 - Am J Clin Nutr. 2007 Dec;86(6):1687-93 23378096 - J Mass Spectrom. 2013 Feb;48(2):234-42 22266733 - Diabetes Care. 2012 Mar;35(3):605-11 15111542 - Diabetes Care. 2004 May;27(5):1182-6 9038835 - Am J Physiol. 1997 Jan;272(1 Pt 1):C289-94 10984107 - Lipids. 2000 Aug;35(8):839-54 10546690 - JAMA. 1999 Oct 27;282(16):1519-22 21890434 - J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Oct 1;879(27):2871-6 19356713 - Cell Metab. 2009 Apr;9(4):311-26 19606418 - Biomed Chromatogr. 2010 Mar;24(3):245-52 18585721 - Atherosclerosis. 2009 Jan;202(1):11-7 18682512 - J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9 10975773 - Dig Liver Dis. 2000 Apr;32(3):226-32 17198917 - Am J Hypertens. 2007 Jan;20(1):83-9 16873691 - Diabetes. 2006 Aug;55(8):2277-85 22617590 - Obstet Gynecol. 2012 Jun;119(6):1243-50 20634010 - Brain Dev. 2011 May;33(5):428-31 15496160 - Kidney Int. 2004 Nov;66(5):1890-900 20560578 - J Proteome Res. 2010 Sep 3;9(9):4368-75 |
References_xml | – volume: 124 start-page: 1160 year: 2011 end-page: 1171 ident: CR47 article-title: Role of Perivascular Adipose Tissue-Derived Methyl Palmitate in Vascular Tone Regulation and Pathogenesis of Hypertension publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.027375 – volume: 17 start-page: 448 year: 2011 end-page: 453 ident: CR29 article-title: Metabolite profiles and the risk of developing diabetes publication-title: Nat Med doi: 10.1038/nm.2307 – volume: 33 start-page: 13284 year: 1994 end-page: 13294 ident: CR50 article-title: Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: sequential actions of diacylglycerol and monoacylglycerol lipases publication-title: Biochemistry doi: 10.1021/bi00249a015 – volume: 202 start-page: 11 year: 2009 end-page: 17 ident: CR52 article-title: Uric acid: a marker of increased cardiovascular risk publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.05.022 – volume: 53 start-page: 757 year: 2010 end-page: 767 ident: CR26 article-title: Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men publication-title: Diabetologia doi: 10.1007/s00125-009-1637-8 – volume: 35 start-page: 839 year: 2000 end-page: 854 ident: CR51 article-title: Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty rats publication-title: Lipids doi: 10.1007/S11745-000-0593-z – volume: 35 start-page: 605 year: 2012 end-page: 611 ident: CR13 article-title: Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation publication-title: Diabetes Care doi: 10.2337/DC11-1577 – volume: 6 start-page: 909 year: 2010 ident: CR9 article-title: Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes publication-title: Mol BioSyst doi: 10.1039/b914182k – volume: 398 start-page: 107 year: 2006 end-page: 112 ident: CR32 article-title: Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins publication-title: Biochem J doi: 10.1042/BJ20060221 – volume: 36 start-page: 2388 year: 2013 end-page: 2394 ident: CR5 article-title: Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study publication-title: Diabetes Care doi: 10.2337/dc12-1971 – volume: 165 start-page: 742 year: 2005 end-page: 748 ident: CR53 article-title: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study publication-title: Arch Intern Med doi: 10.1001/archinte.165.7.742 – volume: 119 start-page: 1243 year: 2012 end-page: 1250 ident: CR48 article-title: Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia publication-title: Obstet Gynecol doi: 10.1097/AOG.0b013e318255004e – volume: 282 start-page: 1519 year: 1999 end-page: 1522 ident: CR1 article-title: The spread of the obesity epidemic in the United States, 1991-1998 publication-title: JAMA doi: 10.1001/jama.282.16.1519 – volume: 93 start-page: 4075 year: 2008 end-page: 4079 ident: CR2 article-title: High adiponectin concentrations are associated with the metabolically healthy obese phenotype publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-2724 – volume: 34 start-page: 1095 year: 2010 end-page: 1098 ident: CR58 article-title: Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2010.44 – volume: 168 start-page: 1617 year: 2008 end-page: 1624 ident: CR3 article-title: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) publication-title: Arch Intern Med doi: 10.1001/archinte.168.15.1617 – volume: 4 start-page: e201301009 year: 2013 ident: CR18 article-title: Statistical methods for the analysis of high-throughput metabolomics data publication-title: Comput Struct Biotechnol J doi: 10.5936/csbj.201301009 – volume: 879 start-page: 2871 year: 2011 end-page: 2876 ident: CR14 article-title: Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC/Q-TOF MS) publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2011.08.014 – volume: 287 start-page: R147 year: 2004 end-page: R156 ident: CR38 article-title: Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00103.2004 – volume: 272 start-page: C289 year: 1997 end-page: C294 ident: CR41 article-title: Pathways of hepatic oxalate synthesis and their regulation publication-title: Am J Physiol doi: 10.1152/ajpcell.1997.272.1.C289 – volume: 5 start-page: e10883 year: 2010 ident: CR23 article-title: α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population publication-title: PLoS ONE doi: 10.1371/journal.pone.0010883 – volume: 481 start-page: 30 year: 2009 end-page: 36 ident: CR39 article-title: High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2008.10.011 – volume: 457 start-page: 480 year: 2009 end-page: 484 ident: CR60 article-title: A core gut microbiome in obese and lean twins publication-title: Nature doi: 10.1038/nature07540 – volume: 122 start-page: 1958 year: 2012 end-page: 1959 ident: CR34 article-title: Malonyl-CoA: the regulator of fatty acid synthesis and oxidation publication-title: J Clin Invest doi: 10.1172/JCI63967 – volume: 100 start-page: 149 year: 2015 end-page: 158 ident: CR28 article-title: Dietary protein intake affects amino Acid and acylcarnitine metabolism in infants aged 6 months publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3157 – volume: 66 start-page: 1890 year: 2004 end-page: 1900 ident: CR42 article-title: Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity publication-title: Kidney Int doi: 10.1111/j.1523-1755.2004.00963.x – volume: 1827 start-page: 401 year: 2013 end-page: 410 ident: CR36 article-title: The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues publication-title: Biochim Biophys Acta doi: 10.1016/j.bbabio.2012.11.014 – volume: 19 start-page: 883 year: 2008 end-page: 889 ident: CR44 article-title: Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery publication-title: Obes Surg doi: 10.1007/s11695-008-9521-z – volume: 40 start-page: D109 year: 2011 end-page: D114 ident: CR20 article-title: KEGG for integration and interpretation of large-scale molecular data sets publication-title: Nucleic Acids Res doi: 10.1093/nar/gkr988 – volume: 97 start-page: 2482 year: 2012 end-page: 2488 ident: CR4 article-title: Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-3475 – volume: 55 start-page: 2277 year: 2006 end-page: 2285 ident: CR35 article-title: Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects publication-title: Diabetes doi: 10.2337/db06-0062 – volume: 32 start-page: 226 year: 2000 end-page: 232 ident: CR45 article-title: 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease publication-title: Dig Liver Dis doi: 10.1016/S1590-8658(00)80825-7 – volume: 18 start-page: 1695 year: 2009 end-page: 1700 ident: CR12 article-title: Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2009.510 – volume: 254 start-page: 55 year: 2003 end-page: 59 ident: CR37 article-title: Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans publication-title: Mol Cell Biochem doi: 10.1023/A:1027332523114 – volume: 86 start-page: 1687 year: 2007 end-page: 1693 ident: CR61 article-title: Influence of acute phytochemical intake on human urinary metabolomic profiles publication-title: Am J Clin Nutr doi: 10.1093/ajcn/86.6.1687 – volume: 30 start-page: 801 year: 2010 end-page: 806 ident: CR56 article-title: Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol publication-title: Nutr Res doi: 10.1016/j.nutres.2010.09.007 – volume: 90 start-page: 4145 year: 2005 end-page: 4150 ident: CR6 article-title: The metabolically healthy but obese individual presents a favorable inflammation profile publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0482 – volume: 33 start-page: 428 year: 2011 end-page: 431 ident: CR33 article-title: Propionic acidemia mimicking diabetic ketoacidosis publication-title: Brain Dev doi: 10.1016/j.braindev.2010.06.016 – volume: 5 start-page: 660 year: 2012 end-page: 670 ident: CR25 article-title: Childhood obesity is associated with changes in the serum metabolite profile publication-title: Obes Facts doi: 10.1159/000343204 – volume: 9 start-page: 311 year: 2009 end-page: 326 ident: CR24 article-title: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance publication-title: Cell Metab doi: 10.1016/j.cmet.2009.02.002 – volume: 37 start-page: 4553 year: 1998 end-page: 4567 ident: CR49 article-title: Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis publication-title: Biochemistry doi: 10.1021/bi9722507 – volume: 5 start-page: 23 year: 2002 end-page: 36 ident: CR55 article-title: Tagatose, the new GRAS sweetener and health product publication-title: J Med Food doi: 10.1089/109662002753723197 – volume: 320 start-page: 345 year: 1996 end-page: 357 ident: CR22 article-title: Mammalian mitochondrial beta-oxidation publication-title: Biochem J doi: 10.1042/bj3200345 – volume: 135 start-page: 1935 year: 2008 end-page: 1944 ident: CR46 article-title: Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.09.018 – volume: 9 start-page: 4368 year: 2010 end-page: 4375 ident: CR11 article-title: Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS) publication-title: J Proteome Res doi: 10.1021/pr100101p – volume: 32 start-page: 2297 year: 2009 end-page: 2299 ident: CR16 article-title: Are metabolically normal but obese individuals at lower risk for all-cause mortality? publication-title: Diabetes Care doi: 10.2337/dc09-0574 – volume: 27 start-page: 1182 year: 2004 end-page: 1186 ident: CR15 article-title: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? publication-title: Diabetes Care doi: 10.2337/diacare.27.5.1182 – volume: 4 start-page: 214 year: 2008 ident: CR27 article-title: Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity publication-title: Mol Syst Biol doi: 10.1038/msb.2008.50 – volume: 24 start-page: 242 year: 2010 end-page: 252 ident: CR10 article-title: Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia publication-title: Biomed Chromatogr – volume: 10 start-page: 723 year: 2014 end-page: 736 ident: CR30 article-title: Branched-chain amino acids in metabolic signalling and insulin resistance publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2014.171 – volume: 86 start-page: 1020 year: 2001 end-page: 1025 ident: CR7 article-title: What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? publication-title: J Clin Endocrinol Metab – volume: 10 start-page: 109 year: 2008 end-page: 134 ident: CR57 article-title: a new antidiabetic and obesity control drug publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2008.00866.x – volume: 20 start-page: 83 year: 2007 end-page: 89 ident: CR54 article-title: Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2006.06.015 – volume: S6 start-page: 001 year: 2012 ident: CR8 article-title: Metabolomics: approaches and applications to diabetes research publication-title: J Diabetes Metab – volume: 48 start-page: 905 year: 2006 end-page: 915 ident: CR43 article-title: Body size and 24-hour urine composition publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2006.09.004 – volume: 48 start-page: 234 year: 2013 end-page: 242 ident: CR17 article-title: True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data publication-title: J Mass Spectrom doi: 10.1002/jms.3154 – volume: 9 start-page: 44 year: 2012 end-page: 66 ident: CR19 article-title: Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics publication-title: Metabolomics doi: 10.1007/s11306-012-0434-4 – volume: 29 start-page: 99 year: 2007 end-page: 108 ident: CR59 article-title: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00194.2006 – volume: 54 start-page: 8 year: 2005 end-page: 14 ident: CR31 article-title: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.54.1.8 – volume: 63 start-page: 2344 year: 2014 end-page: 2355 ident: CR40 article-title: Role of vascular oxidative stress in obesity and metabolic syndrome publication-title: Diabetes doi: 10.2337/db13-0719 – volume: 26 start-page: 2342 year: 2010 end-page: 2344 ident: CR21 article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq418 – volume: 17 start-page: 448 year: 2011 ident: BFijo201565_CR29 publication-title: Nat Med doi: 10.1038/nm.2307 – volume: S6 start-page: 001 year: 2012 ident: BFijo201565_CR8 publication-title: J Diabetes Metab – volume: 27 start-page: 1182 year: 2004 ident: BFijo201565_CR15 publication-title: Diabetes Care doi: 10.2337/diacare.27.5.1182 – volume: 55 start-page: 2277 year: 2006 ident: BFijo201565_CR35 publication-title: Diabetes doi: 10.2337/db06-0062 – volume: 287 start-page: R147 year: 2004 ident: BFijo201565_CR38 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00103.2004 – volume: 5 start-page: 23 year: 2002 ident: BFijo201565_CR55 publication-title: J Med Food doi: 10.1089/109662002753723197 – volume: 18 start-page: 1695 year: 2009 ident: BFijo201565_CR12 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2009.510 – volume: 32 start-page: 2297 year: 2009 ident: BFijo201565_CR16 publication-title: Diabetes Care doi: 10.2337/dc09-0574 – volume: 481 start-page: 30 year: 2009 ident: BFijo201565_CR39 publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2008.10.011 – volume: 5 start-page: 660 year: 2012 ident: BFijo201565_CR25 publication-title: Obes Facts doi: 10.1159/000343204 – volume: 282 start-page: 1519 year: 1999 ident: BFijo201565_CR1 publication-title: JAMA doi: 10.1001/jama.282.16.1519 – volume: 40 start-page: D109 year: 2011 ident: BFijo201565_CR20 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkr988 – volume: 29 start-page: 99 year: 2007 ident: BFijo201565_CR59 publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00194.2006 – volume: 457 start-page: 480 year: 2009 ident: BFijo201565_CR60 publication-title: Nature doi: 10.1038/nature07540 – volume: 254 start-page: 55 year: 2003 ident: BFijo201565_CR37 publication-title: Mol Cell Biochem doi: 10.1023/A:1027332523114 – volume: 10 start-page: 723 year: 2014 ident: BFijo201565_CR30 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2014.171 – volume: 165 start-page: 742 year: 2005 ident: BFijo201565_CR53 publication-title: Arch Intern Med doi: 10.1001/archinte.165.7.742 – volume: 122 start-page: 1958 year: 2012 ident: BFijo201565_CR34 publication-title: J Clin Invest doi: 10.1172/JCI63967 – volume: 135 start-page: 1935 year: 2008 ident: BFijo201565_CR46 publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.09.018 – volume: 10 start-page: 109 year: 2008 ident: BFijo201565_CR57 publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2008.00866.x – volume: 20 start-page: 83 year: 2007 ident: BFijo201565_CR54 publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2006.06.015 – volume: 9 start-page: 4368 year: 2010 ident: BFijo201565_CR11 publication-title: J Proteome Res doi: 10.1021/pr100101p – volume: 119 start-page: 1243 year: 2012 ident: BFijo201565_CR48 publication-title: Obstet Gynecol doi: 10.1097/AOG.0b013e318255004e – volume: 168 start-page: 1617 year: 2008 ident: BFijo201565_CR3 publication-title: Arch Intern Med doi: 10.1001/archinte.168.15.1617 – volume: 33 start-page: 13284 year: 1994 ident: BFijo201565_CR50 publication-title: Biochemistry doi: 10.1021/bi00249a015 – volume: 48 start-page: 905 year: 2006 ident: BFijo201565_CR43 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2006.09.004 – volume: 37 start-page: 4553 year: 1998 ident: BFijo201565_CR49 publication-title: Biochemistry doi: 10.1021/bi9722507 – volume: 93 start-page: 4075 year: 2008 ident: BFijo201565_CR2 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-2724 – volume: 54 start-page: 8 year: 2005 ident: BFijo201565_CR31 publication-title: Diabetes doi: 10.2337/diabetes.54.1.8 – volume: 26 start-page: 2342 year: 2010 ident: BFijo201565_CR21 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq418 – volume: 320 start-page: 345 year: 1996 ident: BFijo201565_CR22 publication-title: Biochem J doi: 10.1042/bj3200345 – volume: 53 start-page: 757 year: 2010 ident: BFijo201565_CR26 publication-title: Diabetologia doi: 10.1007/s00125-009-1637-8 – volume: 86 start-page: 1020 year: 2001 ident: BFijo201565_CR7 publication-title: J Clin Endocrinol Metab – volume: 4 start-page: 214 year: 2008 ident: BFijo201565_CR27 publication-title: Mol Syst Biol doi: 10.1038/msb.2008.50 – volume: 33 start-page: 428 year: 2011 ident: BFijo201565_CR33 publication-title: Brain Dev doi: 10.1016/j.braindev.2010.06.016 – volume: 398 start-page: 107 year: 2006 ident: BFijo201565_CR32 publication-title: Biochem J doi: 10.1042/BJ20060221 – volume: 86 start-page: 1687 year: 2007 ident: BFijo201565_CR61 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/86.6.1687 – volume: 48 start-page: 234 year: 2013 ident: BFijo201565_CR17 publication-title: J Mass Spectrom doi: 10.1002/jms.3154 – volume: 63 start-page: 2344 year: 2014 ident: BFijo201565_CR40 publication-title: Diabetes doi: 10.2337/db13-0719 – volume: 4 start-page: e201301009 year: 2013 ident: BFijo201565_CR18 publication-title: Comput Struct Biotechnol J doi: 10.5936/csbj.201301009 – volume: 202 start-page: 11 year: 2009 ident: BFijo201565_CR52 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.05.022 – volume: 36 start-page: 2388 year: 2013 ident: BFijo201565_CR5 publication-title: Diabetes Care doi: 10.2337/dc12-1971 – volume: 272 start-page: C289 year: 1997 ident: BFijo201565_CR41 publication-title: Am J Physiol doi: 10.1152/ajpcell.1997.272.1.C289 – volume: 5 start-page: e10883 year: 2010 ident: BFijo201565_CR23 publication-title: PLoS ONE doi: 10.1371/journal.pone.0010883 – volume: 124 start-page: 1160 year: 2011 ident: BFijo201565_CR47 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.027375 – volume: 9 start-page: 311 year: 2009 ident: BFijo201565_CR24 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.02.002 – volume: 879 start-page: 2871 year: 2011 ident: BFijo201565_CR14 publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2011.08.014 – volume: 30 start-page: 801 year: 2010 ident: BFijo201565_CR56 publication-title: Nutr Res doi: 10.1016/j.nutres.2010.09.007 – volume: 1827 start-page: 401 year: 2013 ident: BFijo201565_CR36 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbabio.2012.11.014 – volume: 34 start-page: 1095 year: 2010 ident: BFijo201565_CR58 publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2010.44 – volume: 66 start-page: 1890 year: 2004 ident: BFijo201565_CR42 publication-title: Kidney Int doi: 10.1111/j.1523-1755.2004.00963.x – volume: 24 start-page: 242 year: 2010 ident: BFijo201565_CR10 publication-title: Biomed Chromatogr – volume: 90 start-page: 4145 year: 2005 ident: BFijo201565_CR6 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0482 – volume: 32 start-page: 226 year: 2000 ident: BFijo201565_CR45 publication-title: Dig Liver Dis doi: 10.1016/S1590-8658(00)80825-7 – volume: 35 start-page: 839 year: 2000 ident: BFijo201565_CR51 publication-title: Lipids doi: 10.1007/S11745-000-0593-z – volume: 9 start-page: 44 year: 2012 ident: BFijo201565_CR19 publication-title: Metabolomics doi: 10.1007/s11306-012-0434-4 – volume: 19 start-page: 883 year: 2008 ident: BFijo201565_CR44 publication-title: Obes Surg doi: 10.1007/s11695-008-9521-z – volume: 6 start-page: 909 year: 2010 ident: BFijo201565_CR9 publication-title: Mol BioSyst doi: 10.1039/b914182k – volume: 97 start-page: 2482 year: 2012 ident: BFijo201565_CR4 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-3475 – volume: 100 start-page: 149 year: 2015 ident: BFijo201565_CR28 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3157 – volume: 35 start-page: 605 year: 2012 ident: BFijo201565_CR13 publication-title: Diabetes Care doi: 10.2337/DC11-1577 – reference: 14674682 - Mol Cell Biochem. 2003 Dec;254(1-2):55-9 – reference: 16873691 - Diabetes. 2006 Aug;55(8):2277-85 – reference: 16686602 - Biochem J. 2006 Aug 15;398(1):107-12 – reference: 17941870 - Diabetes Obes Metab. 2008 Feb;10 (2):109-34 – reference: 22080510 - Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14 – reference: 20634010 - Brain Dev. 2011 May;33(5):428-31 – reference: 17190852 - Physiol Genomics. 2007 Apr 24;29(2):99-108 – reference: 18065587 - Am J Clin Nutr. 2007 Dec;86(6):1687-93 – reference: 18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24 – reference: 19356713 - Cell Metab. 2009 Apr;9(4):311-26 – reference: 19010326 - Gastroenterology. 2008 Dec;135(6):1935-44, 1944.e1 – reference: 15616005 - Diabetes. 2005 Jan;54(1):8-14 – reference: 17198917 - Am J Hypertens. 2007 Jan;20(1):83-9 – reference: 18682704 - Mol Syst Biol. 2008;4:214 – reference: 19606418 - Biomed Chromatogr. 2010 Mar;24(3):245-52 – reference: 24688690 - Comput Struct Biotechnol J. 2013 Mar 22;4:e201301009 – reference: 15111542 - Diabetes Care. 2004 May;27(5):1182-6 – reference: 9038835 - Am J Physiol. 1997 Jan;272(1 Pt 1):C289-94 – reference: 10984107 - Lipids. 2000 Aug;35(8):839-54 – reference: 20111019 - Obesity (Silver Spring). 2010 Sep;18(9):1695-700 – reference: 21147362 - Nutr Res. 2010 Dec;30(12 ):801-6 – reference: 22508708 - J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8 – reference: 21423183 - Nat Med. 2011 Apr;17(4):448-53 – reference: 18952046 - Arch Biochem Biophys. 2009 Jan 1;481(1):30-6 – reference: 19729521 - Diabetes Care. 2009 Dec;32(12):2297-9 – reference: 23491523 - Diabetes Care. 2013 Aug;36(8):2388-94 – reference: 17162145 - Am J Kidney Dis. 2006 Dec;48(6):905-15 – reference: 23108202 - Obes Facts. 2012;5(5):660-70 – reference: 23220394 - Biochim Biophys Acta. 2013 Mar;1827(3):401-10 – reference: 7947736 - Biochemistry. 1994 Nov 15;33(45):13284-94 – reference: 20560578 - J Proteome Res. 2010 Sep 3;9(9):4368-75 – reference: 18585721 - Atherosclerosis. 2009 Jan;202(1):11-7 – reference: 25368978 - J Clin Endocrinol Metab. 2015 Jan;100(1):149-58 – reference: 10975773 - Dig Liver Dis. 2000 Apr;32(3):226-32 – reference: 23378096 - J Mass Spectrom. 2013 Feb;48(2):234-42 – reference: 11238480 - J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5 – reference: 21844078 - Circulation. 2011 Sep 6;124(10 ):1160-71 – reference: 20628077 - Bioinformatics. 2010 Sep 15;26(18):2342-4 – reference: 15496160 - Kidney Int. 2004 Nov;66(5):1890-900 – reference: 15031134 - Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R147-56 – reference: 19043404 - Nature. 2009 Jan 22;457(7228):480-4 – reference: 22833869 - J Clin Invest. 2012 Jun;122(6):1958-9 – reference: 21890434 - J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Oct 1;879(27):2871-6 – reference: 22266733 - Diabetes Care. 2012 Mar;35(3):605-11 – reference: 15855252 - J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50 – reference: 20076942 - Diabetologia. 2010 Apr;53(4):757-67 – reference: 20526369 - PLoS One. 2010 May 28;5(5):e10883 – reference: 18431611 - Obes Surg. 2009 Jul;19(7):883-9 – reference: 10546690 - JAMA. 1999 Oct 27;282(16):1519-22 – reference: 25287287 - Nat Rev Endocrinol. 2014 Dec;10(12):723-36 – reference: 18682512 - J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9 – reference: 20567778 - Mol Biosyst. 2010 May;6(5):909-21 – reference: 24550188 - Diabetes. 2014 Jul;63(7):2344-55 – reference: 8973539 - Biochem J. 1996 Dec 1;320 ( Pt 2):345-57 – reference: 15824292 - Arch Intern Med. 2005 Apr 11;165(7):742-8 – reference: 12511110 - J Med Food. 2002 Spring;5(1):23-36 – reference: 20212498 - Int J Obes (Lond). 2010 Jun;34(6):1095-8 – reference: 22617590 - Obstet Gynecol. 2012 Jun;119(6):1243-50 – reference: 9521776 - Biochemistry. 1998 Mar 31;37(13):4553-67 |
SSID | ssj0005502 ssj0033214 |
Score | 2.4997735 |
Snippet | Objectives:
Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen... Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both... OBJECTIVES: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen... International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65 Objectives:Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen... Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1241 |
SubjectTerms | 631/443/319/1642/393 631/443/319/320 692/308/174 Adult Amine oxidase (flavin-containing) Biosynthesis Blood Glucose - metabolism Body Fat Distribution Body Mass Index Body size Body weight loss Chromatography Clinical outcomes Diabetes Discriminant analysis Dyslipidemia Epidemiology Fatty acids Female Gas chromatography Glycerol Glycolic acid Health care Health Promotion and Disease Prevention Hospitals Humans Hyperglycemia Hypertension Indexing Inflammation - metabolism Inflammation - physiopathology Internal Medicine Isoleucine Leucine Liquid chromatography Male Mass spectrometry Mass spectroscopy Medical research Medicine Medicine & Public Health Medicine, Experimental Metabolic Diseases Metabolic disorders Metabolic Networks and Pathways Metabolic pathways Metabolism Metabolites Metabolome Metabolomics Metabolomics - methods Obesity Obesity - metabolism Obesity - physiopathology original-article Palmitic acid Phenotypes Phenylalanine Preventive medicine Public Health Regression analysis Risk Factors Scientific imaging Spectroscopy Taiwan Topology Uric acid Valine |
Title | The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity |
URI | https://link.springer.com/article/10.1038/ijo.2015.65 https://www.ncbi.nlm.nih.gov/pubmed/25907313 https://www.proquest.com/docview/1701284254 https://www.proquest.com/docview/2331625726 https://www.proquest.com/docview/1702089167 https://www.proquest.com/docview/1732826403 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR39a9Qw9KEbiCCi51d1zghTQahrmzRNf5I5N4bgIeLwfitJm8LJrZ1eh-y_970m7d3NsV_KQV5zad7L-8j7Atircl6r1JLTnZtQSKVDk1VVKHglIhNlJT4o2mIqT07Fl1k68xduSx9WOfDEnlFXbUl35PtUNzwhn5H4eP47pK5R5F31LTRuwzaVLiPjK5tlqxCPNBprSXHqyDNURUSpn_pkvYir_fkvSgOM0w8kYtbE01UmvSalrrhNe2l0_ADuezWSHTi8P4RbtplA8HluO_aW-VqfCzYdSu1P4M5X70SfwD13VcdcBtIEJivVEV_u254vH8FPJCB2ZjskkkV7Zplr7o2LYbqpGDUy_qsv8beracLmzQCMM7vkysseUpuG1OIFa10Lgsdwenz04_Ak9F0YwjLN8i60Nk9QAxcRt7KWKuOxRVSkZYrSNeK1zlXNuZQmjxNtSqWEthJ5Zp0L1EV1LvgT2Graxj4DZhSZ4lKbXCtR5akm9dRmcWJ4JaPSBPB-2Pyi9CXKqVPGouhd5VwViKmCMFXINIC9EfjcVea4HuwVYbFwXz6e5-IASUkh0SRZAO96CDrR-G-l9okJuGaqjbUBubMBiSex3BweKKXwnGBZrOj22uGE8xhN0CyRAbweh2liCn5rbHvRT5FECvX47CYYjsazRCwF8NQR6bgraOEiI49x5M1AtWvr-3_Lnt_8HS_gLgG6KMgd2Or-XNiXqJl1Zrc_fvhUh_EubH86mn77_g8P3zRc |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dT9RAcIKYKIkxen5VUdYENDGptN3tdvtgDAHJIXBPEHkru-1ecuTooVdC7k_5G53ptuUOCW-8NE12ut3uzM5H5wtgvUj5UMWWnO7c-EIq7ZukKHzBCxGYIMnxQtEWA9k_Fj9P4pMl-NvmwlBYZcsTa0ZdTHL6R75JdcMj8hmJ7xe_feoaRd7VtoWGI4t9O7tCk236bW8H8bsRRbs_jrb7ftNVwM_jJK18a9MINUoRcCuHUiU8tDh1nMcoLQI-1Kkaci6lScNIm1wpoa1EHjBMBepWOhUc530ADwXnCdXqV9tzISVx0NWu4tQBqK3CiFpG3CQHBlxtjs4o7TCMv5JImxOHN4XCnFS84aatpd_uM3jaqK1sy9HZc1iyZQ-8nZGt2CfW1BYds0Fb2r8Hjw4bp30Pnrhfg8xlPPWgd62q4sN1m_XpC_iFBMvObYVEOZ6cW-aaieNimC4LRo2Tr_QM710NFTYqW2Cc2SVzzmpIbUpSw8ds4loevITje8HPK1guJ6V9A8woMv2lNqlWokhjTeqwTcLI8EIGufHgS7v5Wd6URKfOHOOsds1zlSGmMsJUJmMP1jvgC1cJ5HawNcJi5r684x_ZFpKuClGfTjz4XEMQB8G35bpJhMA1Uy2uBcjVBUg8-fnicEspWcN5ptn1Obl1OOI8RJM3iaQHH7thmpiC7Uo7uayniAKFdkNyFwxHY10iljx47Yi02xW0qFFwhDiy0VLt3Pr-37K3d3_HGjzuHx0eZAd7g_13sEIPuQjMVViu_lza96gVVuZDfRQZnN732f8Hfa5uSg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DSGNCEhBOUrYzAjbSAhhSZxYjsPCE2UamNQ8cBE34KdOFJRl26009S_xq_jLk76Maa97aWq5Ivj-M734fsC2CtSXqrEktOdGz8WSvtGFoUf8yIOTCBz_KFoi4E4PIm_DJPhBvxtc2EorLLliTWjLiY53ZF3qW54RD6juFs2YRHfe_2PZ-c-dZAiT2vbTsORyLGdX6L5Nv1w1ENc70dR__OPT4d-02HAzxOZznxr0wi1yzjgVpRCSR5afE2SJyg5Al7qVJWcC2HSMNImVyrWViA_KNMY9SydxhznvQN3JUexiWdJDuUyvCQJFnWsOHUDaisyosaRNImCAVfd0W9KQQyT9yTeVkTjVQGxIiGvuGxrSdh_CA8aFZYdOJp7BBu26oDXG9kZe8OaOqNjNmjL_Hdg61vjwO_AfXdNyFz2Uwc6S7UVH65brk8fw08kXnZqZ0ig48mpZa6xOC6G6apg1ET5Us_xv6unwkZVC4wzu8TOeQ2pTUUq-ZhNXPuDJ3ByK_h5CpvVpLLPgRlF1wBCm1SruEgTTaqxlWFkeCGC3Hjwrt38LG_Ko1OXjnFWu-m5yhBTGWEqE4kHewvgM1cV5HqwXcJi5r58wUuyAyRjFaJuLT14W0MQN8G35bpJisA1U12uNcidNUjkAvn6cEspWcOFptnyzFw7HHEeovkrI-HB68UwTUyBd5WdXNRTRIFCG0LeBMPRcBeIJQ-eOSJd7Apa1yhEQhzZb6l2ZX3_b9n2zd-xC1t46rOvR4PjF3CPnnHBmDuwOftzYV-igjgzr-qTyODXbR_9f0SKcqw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+metabolome+profiling+and+pathway+analysis+in+metabolic+healthy+and+abnormal+obesity&rft.jtitle=International+Journal+of+Obesity&rft.au=Chen%2C+H-H&rft.au=Tseng%2C+Y+J&rft.au=Wang%2C+S-Y&rft.au=Tsai%2C+Y-S&rft.date=2015-08-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0307-0565&rft.eissn=1476-5497&rft.volume=39&rft.issue=8&rft.spage=1241&rft.epage=1248&rft_id=info:doi/10.1038%2Fijo.2015.65&rft.externalDocID=10_1038_ijo_2015_65 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |